Illumina Buchwert je Aktie
Was ist das Buchwert je Aktie von Illumina?
Buchwert je Aktie von Illumina, Inc. ist 7,577.63
Was ist die Definition von Buchwert je Aktie?
Der Buchwert pro Aktie ist das Vermögen eines Unternehmens abzüglich der Verbindlichkeiten geteilt durch die Anzahl der ausstehenden Aktien.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Buchwert je Aktie von Unternehmen in Miscellaneous Sektor auf LSE im Vergleich zu Illumina
Was macht Illumina?
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.
Unternehmen mit buchwert je aktie ähnlich Illumina
- ANSYS hat Buchwert je Aktie von 7,294.00
- FuelCell hat Buchwert je Aktie von 7,305.41
- Investis SA hat Buchwert je Aktie von 7,385.18
- First Solar hat Buchwert je Aktie von 7,391.53
- La Societe Industrielle et Financiere de l'Artois hat Buchwert je Aktie von 7,565.32
- Enea AB (publ) hat Buchwert je Aktie von 7,565.43
- Illumina hat Buchwert je Aktie von 7,577.63
- PDL Biopharma Inc hat Buchwert je Aktie von 7,581.60
- Maruwa Co hat Buchwert je Aktie von 7,585.88
- Mountview Estates P.L.C hat Buchwert je Aktie von 7,677.82
- Maharashtra Scooters hat Buchwert je Aktie von 7,679.04
- N.B.I. Industrial Finance hat Buchwert je Aktie von 7,696.01
- CARBO Ceramics hat Buchwert je Aktie von 7,717.17